HealthcareHuma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
Huma Therapeutics (“Huma”), a leading global digital health company, today announced a partnership with Camden Health Partners and UCLPartners to deliver a digital-first programme aimed at identifying more people living in North Central London who are at high risk of, or who have undiagnosed, cardiovascular disease (CVD) and helping them to adopt new behaviours to help modify the condition. The programme will form a blueprint for potential national adoption. Supported by a grant from the Small Business Research Initiative...